CAIV-T (live attenuated influenza vaccine, trivalent, types A & B, liquid formulation)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAIV-T (live attenuated influenza vaccine, trivalent, types A & B, liquid formulation), covering 2021-09-13 to 2021-09-13. Get the full timeline:
Most recent: Clinical Trial Update: Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold Adapted (CAIV-T) in Healthy Adults [Phase 3]